Literature DB >> 16454167

Who Expert Committee on Biological Standardization.

.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16454167

Source DB:  PubMed          Journal:  World Health Organ Tech Rep Ser        ISSN： 0512-3054


× No keyword cloud information.
  12 in total

1.  Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Quantification of IgM and IgA anti-pneumococcal capsular polysaccharides by a new ELISA assay: a valuable diagnostic and prognostic tool for common variable immunodeficiency.

Authors:  F M Cavaliere; C Milito; H Martini; M Schlesier; R Dräger; K Schütz; G Brunetti; A M Pesce; V Thon; K Warnatz; I Quinti
Journal:  J Clin Immunol       Date:  2012-12-29       Impact factor: 8.317

3.  Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.

Authors:  Dennis W Metzger; Yoichi Furuya; Sharon L Salmon; Sean Roberts; Keer Sun
Journal:  J Infect Dis       Date:  2015-02-03       Impact factor: 5.226

4.  The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.

Authors:  Johanna Nagel; Pierre Geborek; Tore Saxne; Göran Jönsson; Martin Englund; Ingemar F Petersson; Jan-Åke Nilsson; Lennart Truedsson; Meliha C Kapetanovic
Journal:  Arthritis Res Ther       Date:  2015-05-19       Impact factor: 5.156

Review 5.  Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review.

Authors:  Cornelius Remschmidt; Thomas Harder; Ole Wichmann; Christian Bogdan; Gerhard Falkenhorst
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

6.  Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle.

Authors:  Pedro Cecílio; James Oristian; Claudio Meneses; Tiago D Serafim; Jesus G Valenzuela; Anabela Cordeiro da Silva; Fabiano Oliveira
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.996

7.  Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes.

Authors:  Lindsay R Grant; Sarah E O'Brien; Polly Burbidge; Mitch Haston; Marta Zancolli; Lucy Cowell; Marina Johnson; Robert C Weatherholtz; Raymond Reid; Mathuram Santosham; Katherine L O'Brien; David Goldblatt
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

Review 8.  The immunological mechanisms that control pneumococcal carriage.

Authors:  Simon P Jochems; Jeffrey N Weiser; Richard Malley; Daniela M Ferreira
Journal:  PLoS Pathog       Date:  2017-12-21       Impact factor: 6.823

9.  IGA Antibody Induced by Immunization With Pneumococcal Polysaccharides Is a Prognostic Tool in Common Variable Immune Deficiencies.

Authors:  Federica Pulvirenti; Cinzia Milito; Filomena Monica Cavaliere; Ivano Mezzaroma; Francesco Cinetto; Isabella Quinti
Journal:  Front Immunol       Date:  2020-06-24       Impact factor: 7.561

10.  A Novel High-Potency Tetanus Vaccine.

Authors:  Amanda Przedpelski; William H Tepp; Sabine Pellett; Eric A Johnson; Joseph T Barbieri
Journal:  mBio       Date:  2020-08-11       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.